From: Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
 Characteristics
N (%)
Histology
Serous
179 (88.2)
Non-serous1
24 (11.8)
FIGO stage
II
9 (4.4)
III
160 (78.8)
IV
34 (16.7)
Grade
1
7 (3.4)
2
45 (22.2)
3
150 (73.9)
Unkown
1 (0.5)
Residual tumor
No
141 (69.5)
Yes
62 (30.5)
Total
203 (100.0)